Purification and partial characterization of two phospholipases A2 from Bothrops leucurus (white-tailed-jararaca) snake venom

Biochimie

Volumn 89, Issue 3, 2007, Pages 319-328

  Higuchi, D A ^a   Barbosa, C M V ^a   Bincoletto, C ^a   Chagas, J R ^a   Magalhaes, A ^c   Richardson, M ^c   Sanchez, E F ^c   Pesquero, J B ^b   Araujo, R C ^a   Pesquero, J L ^a,d  

^a UNIVERSIDADE DE MOGI DAS CRUZES   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c Ezequiel Dias Foundation   (Brazil)

^d UFMG   (Brazil)

Author keywords

Angiogenesis; Blood coagulation; Bothrops leucurus; PLA2; Platelet aggregation; Snake venom

Indexed keywords

ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; ASPARTIC ACID; CALCIUM ION; COLLAGEN; ISOENZYME; LYSINE; PHOSPHOLIPASE A2; SNAKE VENOM;

AMINO TERMINAL SEQUENCE; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; EHRLICH ASCITES TUMOR; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME PURIFICATION; GEL FILTRATION CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; ION EXCHANGE CHROMATOGRAPHY; MALE; MOLECULAR WEIGHT; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; REVERSED PHASE LIQUID CHROMATOGRAPHY; SNAKE; THROMBOCYTE AGGREGATION;

AMINO ACID SEQUENCE; ANIMALS; ANTICOAGULANTS; BLOOD COAGULATION; BOTHROPS; CALCIUM; CARCINOMA, EHRLICH TUMOR; CELL SURVIVAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, ION EXCHANGE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEMOGLOBINS; HUMANS; ISOENZYMES; K562 CELLS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; PHOSPHOLIPASES A; PLATELET AGGREGATION; SEQUENCE ANALYSIS, PROTEIN; SEQUENCE HOMOLOGY, AMINO ACID; SNAKE VENOMS;

BOTHROPS JARARACA; BOTHROPS LEUCURUS;

EID: 33947505341     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2006.10.010     Document Type: Article

References (61)

1. 2 isolated from Bothrops jararacussu snake venom. Biochimie 86 (2004) 731-739
2. Rosing J., and Tans G. Structural and functional properties of snake venom prothrombin activators. Toxicon 30 (1992) 1515-1527
3. Gutiérrez J.M., and Lomonte B. Local tissue damage induced by Bothrops snake venoms. A review, Mem. Inst. Butantan 51 (1989) 211-223
4. Kamiguti A.S., and Sano-Martins I.S. South American snake venoms affecting haemostasis. J. Toxicol.-Toxin Rev. 14 (1995) 359-374
5. Fan H.W., and Cardoso J.L.C. Clinical toxicology of snake bites in South America. In: Meier J., and White J. (Eds). Handbook of Clinical Toxicology of Animal Venoms and Poisons (1995), CRC Press, Boca Raton 667-688
6. Da Silva L.R.M., and Nunes B.T. Ophidic accidents by Bothrops leucurus Wagler, 1824 in Bahia, Brazil. Toxicon 31 (1993) 143-144
7. 2: function and pharmacological regulation. Biochem. Pharmacol. 36 (1987) 2429-2436
8. 2 enzymes: classification and characterization. Biochim. Biophys. Acta 1488 (2000) 1-19
9. 2 involved in N-type receptor binding and neurotoxicity. J. Biol. Chem. 272 (1997) 7173-7181
10. 2. Biol. Pharm. Bull. 27 (2004) 1168-1173
11. 2. Biol. Pharm. Bull. 27 (2004) 1158-1164
12. 2 from Vipera ammodytes ammodytes, are critical for binding to factor Xa and for anticoagulant effect. Biochimie 88 (2006) 69-76
13. 2 isolated from Lachesis muta (Bushmaster) snake venom. Toxicon 38 (2000) 961-972
14. Chiou S.H., Raynor R.L., Zheng B., Chambers T.C., and Kuo J.F. Cobra venom cardiotoxin (cytotoxin) isoforms and neurotoxin: Comparative potency of protein kinase C inhibition and cancer cell cytotoxicity and modes of enzyme inhibition. Biochemistry 32 (1993) 2062-2067
15. 2 from Bothrops jararacussu snake venom. Biochem. Pharmacol. 64 (2002) 723-732
16. 2 by phosphatidylinositol bisphosphate levels. J. Immunol. 164 (2000) 5398-5402
17. 2 regulation. J. Biol. Chem. 275 (2000) 20146-20156
18. 2. J. Biol. Chem. 273 (1998) 21926-21932
19. 2. J. Biol. Chem. 274 (1999) 8823-8831
20. 2-β. J. Biol. Chem. 274 (1999) 17063-17067
21. 2δ, induced in psoriatic skin. J. Biol. Chem. 279 (2004) 12890-12897
22. 2. J. Biol. Chem. 272 (1997) 16709-16712
23. 2 from bovine pancreas and Crotalus atrox venom. J. Biol. Chem. 260 (1985) 11627-11634
24. 2 blocks phospholipid fatty acid remodeling in murine P388D1 macrophages. J. Biol. Chem. 272 (1997) 29317-29321
25. 2 mechanism inhibition and role in arachidonic acid release. Drug Dev. Res. 10 (1978) 205-220
26. 2 in prostate cancer. Cancer Res. 64 (2004) 6934-6940
27. 2. J. Biol. Chem. 280 (2005) 24987-24998
28. 2. Chin. Med. Sci. J. 19 (2004) 6-12
29. 2 alpha overexpression in stromal cells is correlated with angiogenesis in human colorectal cancer. Modern Pathol. 18 (2005) 212-220
30. 2 deletion enhances colon tumorigenesis. Cancer Res. 65 (2005) 2636-2643
31. Rose D.P., and Connolly J.M. Effects of fatty acids and eicosanoid synthesis inhibitors on the growth of two human prostate cancer cell lines. Prostate 18 (1991) 243-254
32. Ablin R.J., and Shaw M.W. Prostaglandin modulation of prostate tumor growth and metastases. Anticancer Res. 6 (1986) 327-328
33. Fosslien E. Review: molecular pathology of cyclooxygenase-2 in cancer-induced angiogenesis. Ann. Clin. Lab. Sci. 31 (2001) 325-348
34. Souza C.T., Moura M.B., Magalhaes A., Heneine L.G., Olortegui C.C., Diniz C.R., and Sanchez E.F. Inhibition of mutalysin II, a metalloproteinase from bushmaster snake venom by human alpha2-macroglobulin and rabbit immunoglobulin. Comp. Biochem. Physiol. 130B (2001) 155-168
35. 2 using pyrene-labeled phospholipids in the presence of serum albumin. Anal. Biochem. 177 (1989) 103-109
36. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
37. Boschert M.T., Beckert B.W., Puckett C.L., and Concannon M.J. Analysis of lipocyte viability after liposuction. Plast. Reconstr. Surg. 109 (2002) 761-765
38. Sanchez E.F., Santos C.I., Magalhaes A., Diniz C.R., Figueiredo S., Gilroy J., and Richardson M. Isolation of a proteinase with plasminogen-activating activity from Lachesis muta muta (bushmaster) snake venom. Arch. Biochem. Biophys. 378 (2000) 131-141
39. Camey K.U., Velarde D.T., and Sanchez E.F. Pharmacological characterization and neutralization of the venoms used in the production of bothropic antivenom in Brazil. Toxicon 40 (2002) 501-509
40. Valenzuela J.G., Francischetti I.M.B., and Ribeiro J.M. Purification, cloning and synthesis of a novel salivary anti-thrombin from the mosquito Anopheles albimanus. Biochemistry 38 (1999) 11209-11215
41. Ferreira M.A.N.D., Andrade S.P., Pesquero J.L., Feitosa M.H., Oliveira G.M.R., Rogana E., Nogueira J.C., and Beraldo W.T. Kallikrein-kinin system in the angiogenesis. In: Bonner G., Fritz H., Unger T.H., Roscher A., and Lupperetz K. (Eds). Recent Progress on Kinins, Agents and Actions Suppl (1992), Karger, Basel 165-174
42. Dagli M.L.Z., Guerra J.L., and Saldiva P.H.N. An experimental study on the lymphatic dissemination of the solid Ehrlich tumor in mice. Braz. J. Vet. Res. Animal Sci. 29 (1992) 97-103
43. Drabkin D.L., and Austin J.H. Spectrophotometric studies. V. A technique for the analysis of undiluted blood and concentrated hemoglobin solutions. J. Biol. Chem. 112 (1935) 105-115
44. Soares A.M., Rodrigues V.M., Homsi-Brandeburgo M.I., Toyama M.H., Lombardi F.R., Arni R.K., and Giglio J.R. A rapid procedure for the isolation of the Lys-49 myotoxin II from Bothrops moojeni (caissaca) venom: biochemical characterization, crystallization, myotoxic and edematogenic activity. Toxicon 36 (1998) 503-514
45. Cintra A.C., Marangoni S., Oliveira B., and Giglio J.R. Bothropstoxin-I: amino acid sequence and function. J. Protein Chem. 12 (1993) 57-64
46. 2's may imply gene duplications. J. Mol. Evol. 41 (1995) 174-179
47. 2 and anticoagulant activities and high myotoxic activity. J. Protein Chem. 18 (1999) 371-378
48. Hati R., Mitra P., Sarker S., and Bhattacharyya K.K. Snake venom hemorrhagins. Crit. Rev. Toxicol. 29 (1999) 1-19
49. Bello C.A., Hermogenes A.L.N., Magalhaes A., Veiga S.S., Gremski L.H., Richardson M., and Sanchez E.F. Isolation and biochemical characterization of a fibrinolytic proteinase from Bothrops leucurus (white-tailed jararaca) snake venom. Biochimie 88 (2006) 189-200
50. A. Magalhaes, H.P.B. Magalhaes, M. Richardson, S. Gontijo, R.N. Ferreira, A.P. Almeida, E.F. Sanchez, Purification and properties of a coagulant thrombin-like enzyme from the venom of Bothrops leucurus, Comp. Biochem. Physiol. Part A in press.
51. Ouyang C., Teng C.M., and Huang F. Characterization of snake venom components acting on blood coagulation and platelet function. Toxicon 30 (1992) 945-966
52. 2 homologue. Int. J. Biochem. Cell. Biol. 32 (2000) 63-71
53. 2 variant, from Bothrops asper snake venom. Nat. Toxins 3 (1995) 26-31
54. 2 in prostate carcinoma cells. Carcinogenesis 26 (2005) 1520-1526
55. 2 levels correlate with apoptosis in human colon tumorigenesis. Clin. Cancer Res. 11 (2005) 2265-2271
56. 2. Arch. Biochem. Biophys. 284 (1991) 352-359
57. 2 from the venoms of rattlesnakes and other pit vipers. Arch. Biochem. Biophys. 394 (2001) 236-244
58. 2 homolog from the venom of Trimeresurus mucrosquamatus. Biochim. Biophys. Acta 1077 (1991) 362-370
59. 2 of two primitive tree vipers Trimeresurus puniceus and Trimeresurus borneensis. FEBS J. 272 (2005) 3015-3025
60. Kaiser I.I., Gutierrez J.M., Plummer D., Aird S.D., and Odell G.V. The amino acid sequence of a myotoxic phospholipase from the venom of Bothrops asper. Arch. Biochem. Biophys. 278 (1990) 319-325
61. 2 from Bothrops erythromelas venom: isolation, cloning and characterization as potent anti-platelet and inductor of prostaglandin I2 release by endothelial cells. Biochem. Pharmacol. 72 (2006) 377-384